Cerity Partners LLC Organogenesis Holdings Inc. Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 74,880 shares of ORGO stock, worth $398,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,880
Previous 50,518
48.22%
Holding current value
$398,361
Previous $161,000
100.62%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ORGO
# of Institutions
133Shares Held
62.5MCall Options Held
4.3KPut Options Held
3.93K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$66.4 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$62.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$27.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$23.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.1MShares$16.5 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $696M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...